(Q51295443)

2 April 2018

http://europepmc.org/abstract/MED/27901576

title

The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients. (English)

1 reference

2 April 2018

http://europepmc.org/abstract/MED/27901576

author

Javad Tavakkoly-Bazzaz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Ghasem Azizi Tabesh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Pantea Izadi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Forouzandeh Fereidooni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Amir Nader Emami Razavi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

30 November 2016

1 reference

2 April 2018

http://europepmc.org/abstract/MED/27901576

published in

Cancer Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

36-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2012

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Cancer incidence and mortality in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Signaling by distinct classes of phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Functional analysis of PIK3CA gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

A novel PIK3CA hotspot mutation in Isfahanian breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutations in breast cancer are associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

Analysis of PIK3CA mutations in breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1247455

10.1080/07357907.2016.1247455

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27901576%20AND%20SRC:MED&resulttype=core&format=json

release_rxchdapklncqdkxgy3r3jdd62q

6 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rxchdapklncqdkxgy3r3jdd62q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference